- HOLLAND J, Sheehan D, Brown S, O'Flanagan S, et al
Immune Response and Cognitive Impairment in Post-COVID Syndrome: A Systematic Review.
Am J Med. 2025;138:698-711.
PubMed Abstract available - PASCULLI P, Zingaropoli MA, Dominelli F, Solimini AG, et al
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study.
Am J Med. 2024 Sep 17:S0002-9343(24)00569-2. doi: 10.1016/j.amjmed.2024.
PubMed Abstract available - XU J, Wu D, Yang J, Zhao Y, et al
Adult Outpatients with Long COVID Infected with SARS-CoV-2 Omicron Variant. Part 1: Oral Microbiota Alterations.
Am J Med. 2025;138:732-741.
PubMed Abstract available - YOO KH, Lee SH, Cho Y, Kim YJ, et al
Synergistic Effect of SARS-CoV-2 Infection and COVID-19 Vaccination on the Risk of Venous Thromboembolism.
Am J Med. 2025;138:673-680.
PubMed Abstract available - MARKSER A, Vockel J, Schneider A, Baumeister-Lingens L, et al
Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review.
Am J Med. 2025;138:681-697.
PubMed Abstract available - SAWANO M, Wu Y, Shah RM, Zhou T, et al
Long COVID Characteristics and Experience: A Descriptive Study From the Yale LISTEN Research Cohort.
Am J Med. 2025;138:712-720.
PubMed Abstract available - SANAL-HAYES NEM, Hayes LD, Mclaughlin M, Berry ECJ, et al
Post-Traumatic Stress Disorder and Complex Post-Traumatic Stress Disorder in People with Long COVID, ME/CFS, and Controls.
Am J Med. 2025;138:742-749.
PubMed Abstract available - ZHANG H, Ouyang S, Qu Y, Li Z, et al
Humoral immune response characteristics of vulnerable populations against SARS-CoV-2 strains EG.5 and JN.1 after infection with strains BA.5 and XBB.
Arch Virol. 2025;170:82.
PubMed Abstract available - GU L, Wang ZJ, Zhang XR, Liu Y, et al
Targeting the liquid-liquid phase separation of nucleocapsid broadly inhibits the replication of SARS-CoV-2 strains.
Biochem Biophys Res Commun. 2025;756:151594.
PubMed Abstract available - KOCHAROVSKAYA MV, Pichkur EB, Ivannikov AD, Kharlampieva DD, et al
Structure and dynamics of Alpha B.1.1.7 SARS-CoV-2 S-protein in complex with Fab of neutralizing antibody REGN10987.
Biochem Biophys Res Commun. 2025;755:151558.
PubMed Abstract available - BARIDAH I, Setyowireni DK, Citta AN, Arguni E, et al
The severity of pediatric COVID-19 during hospitalization is not associated with mortality within six months of discharge.
BMC Pediatr. 2025;25:199.
PubMed Abstract available - POURJOULA F, Mirlohi SH, Ghanbari N
Comparative analysis of croup severity and treatment in pediatric patient: a study of COVID-19 positive vs. negative cases during peak Omicron.
BMC Pediatr. 2025;25:194.
PubMed Abstract available - JIANG S, Wu F
Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk.
Cell. 2025;188:1465-1468.
PubMed Abstract available - CHEN J, Zhang W, Li Y, Liu C, et al
Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor.
Cell. 2025;188:1729-1742.
PubMed Abstract available
Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?
Epidemiol Infect. 2025;153:e44.
PubMed Abstract available- GROEN K, Kuratli R, Enkelmann J, Fernbach S, et al
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.
J Exp Med. 2025;222:e20242039.
PubMed Abstract available - RAO AS, Ugwu N, Onufer AP, Kumova O, et al
Cathelicidin-related antimicrobial peptide (CRAMP) is toxic during neonatal murine influenza virus infection.
J Immunol. 2025 Mar 18:vkae053. doi: 10.1093.
PubMed Abstract available - ZHAO J, Sheng G, Lyu Y, Sun Y, et al
Oral ADC189 for Adults and Adolescents with Uncomplicated Influenza.
J Infect. 2025 Mar 13:106472. doi: 10.1016/j.jinf.2025.106472.
PubMed Abstract available - WONG JY, Cheung JK, Presanis AM, De Angelis D, et al
Assessing the impact of influenza epidemics in Hong Kong.
J Infect Dis. 2025 Mar 19:jiaf140. doi: 10.1093.
PubMed Abstract available - QUACH HQ, Goergen KM, Grill DE, Ovsyannikova IG, et al
IL-8 as a Causal Link Between Aging and Impaired Influenza Antibody Responses in Older Adults.
J Infect Dis. 2025 Mar 17:jiaf148. doi: 10.1093.
PubMed Abstract available - WANG J, Genberg BL, Feder K, Kirk GD, et al
Impact of pandemic-induced service disruptions and behavioral changes on HCV and HIV transmission amongst people who inject drugs: a modeling study.
J Infect Dis. 2024 Dec 6:jiae599. doi: 10.1093.
PubMed Abstract available - MENG Y, Lin Y, Xiong W, Lau EHY, et al
Effective Real-time Transmission Estimations Incorporating Population Viral Load Distributions Amid SARS-CoV-2 Variants and Preexisting Immunity.
J Infect Dis. 2025;231:684-691.
PubMed Abstract available - MADHI SA, Simoes EAF, Acevedo A, Novoa Pizarro JM, et al
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants.
J Infect Dis. 2025;231:e478-e487.
PubMed Abstract available - THAMBI N, Phuah JY, Staupe RP, Tobias LM, et al
Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150.
J Infect Dis. 2025;231:e488-e496.
PubMed Abstract available - PROBOSTE T, Bista D, Clark NJ, Arora S, et al
Ascertainment of Community Exposure Sites to Ross River Virus During the 2020 Outbreak in Brisbane, Australia.
J Infect Dis. 2025;231:e501-e510.
PubMed Abstract available - MAK J, Khan S, Britton A, Rose S, et al
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers.
J Infect Dis. 2024 Nov 13:jiae556. doi: 10.1093.
PubMed Abstract available - WINKEL AMAM, Kozanli E, Haverkort ME, Euser SM, et al
Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern vs Wild Type: An Interplay Between Transmissibility and Immune Status.
J Infect Dis. 2025;231:653-664.
PubMed Abstract available - REILLY C, Mylonakis E, Dewar R, Young B, et al
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.
J Infect Dis. 2025;231:677-683.
PubMed Abstract available - MONTO AS, Foster-Tucker JE, Callear AP, Leis AM, et al
Respiratory Viral Infections From 2015 to 2022 in the HIVE Cohort of American Households: Incidence, Illness Characteristics, and Seasonality.
J Infect Dis. 2025;231:795-804.
PubMed Abstract available - FURUSAWA Y, Kiso M, Uraki R, Sakai-Tagawa Y, et al
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures.
J Virol. 2025 Feb 12:e0221724. doi: 10.1128/jvi.02217.
PubMed Abstract available - KUHN AJ, Outlaw VK, Marcink TC, Yu Z, et al
Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development.
J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159.
PubMed Abstract available - PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
PubMed Abstract available - SAMAAN P, Korosec CS, Budylowski P, Chau SLL, et al
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-gamma and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.
J Virol. 2025 Jan 31:e0168524. doi: 10.1128/jvi.01685.
PubMed Abstract available - WANG X, Dong M, Wu X, Schnepf D, et al
Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice.
J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413.
PubMed Abstract available - MA R, Zhang X, Li R, Dong X, et al
PLSCR1 suppresses SARS-CoV-2 infection by downregulating cell surface ACE2.
J Virol. 2025 Feb 13:e0208524. doi: 10.1128/jvi.02085.
PubMed Abstract available - BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
PubMed Abstract available - BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al
A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.
J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
PubMed Abstract available - EALES O, Shearer FM, McCaw JM
How immunity shapes the long-term dynamics of influenza H3N2.
PLoS Comput Biol. 2025;21:e1012893.
PubMed Abstract available - BAAKLINY M, Ghosn N, Saleh N, Maison P, et al
Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022.
PLoS One. 2025;20:e0318344.
PubMed Abstract available - VICENCIO VV, Viengkham C, Grange N, Norton S, et al
COVID-19 outbreak management in Western Sydney residential aged care homes: A mixed-methods Donabedian evaluation.
PLoS One. 2025;20:e0318490.
PubMed Abstract available - PHIRI MM, Dunkley Y, Di Giacomo E, Lora W, et al
Factors influencing uptake of COVID-19 diagnostics in Sub-Saharan Africa: a rapid scoping review.
PLoS One. 2025;20:e0305512.
PubMed Abstract available - STRINGER WS, Labar AS, Geleris JD, Sholle EV, et al
Three hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validation.
PLoS One. 2025;20:e0316434.
PubMed Abstract available - SUWANAI H, Kanda M, Harada K, Ishii K, et al
Diabetes with COVID-19 was a significant risk factor for mortality, mechanical ventilation, and renal replacement therapies: A multicenter retrospective study in Japan.
PLoS One. 2025;20:e0319801.
PubMed Abstract available - MIRANDA AR, Scotta AV, Cortez MV, Soria EA, et al
Two-years mothering into the pandemic: Impact of the three COVID-19 waves in the Argentinian postpartum women's mental health.
PLoS One. 2025;20:e0294220.
PubMed Abstract available - PADILLA S, Andreo M, Marco P, Marco-Rico A, et al
Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin.
PLoS One. 2025;20:e0319666.
PubMed Abstract available - HO T, Lailo JM, Ramoran E, Mutreja K, et al
Leveraging a digital network of pharmacy professionals to test a technology-assisted model to improve pharmacy access to quality-assured COVID-19 rapid antigen tests approved for self-use in Vietnam.
PLoS One. 2025;20:e0318331.
PubMed Abstract available - CARDOSO CO, Rodrigues Sandoval ES, de Oliveira Chagas LBM, Badra SJ, et al
Neurologic manifestations of COVID-19 and viral test in cerebrospinal fluid.
PLoS One. 2025;20:e0312621.
PubMed Abstract available - TAYLOR-ABDULAI HB, Dzantor EK, Mensah NK, Asumah MN, et al
Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study.
PLoS One. 2025;20:e0319798.
PubMed Abstract available - MALTESE C, Gandhi CK, Ramirez SI, Sznajder KK, et al
Access to lactation consult services during the COVID-19 pandemic and the impact on breastfeeding outcome variables.
PLoS One. 2025;20:e0318749.
PubMed Abstract available - HAMADANI JD, Bhuiyan SA, Hasan MI, Grantham-McGregor S, et al
The effect of exposure to the COVID-19 pandemic on nutritional status and cognitive, motor, and behavioural development among children aged 20 months in rural Bangladesh: A repeated cross-section study between 2020 and 2022.
PLoS One. 2025;20:e0309836.
PubMed Abstract available - MUHAMAD NA, Ma'amor NH, Jamalluddin NH, Rosli IA, et al
Technostress and its associated factors: Burnout and fatigue among Malaysian healthcare workers (HCWs) in state hospitals.
PLoS One. 2025;20:e0319506.
PubMed Abstract available - PEREIRA AMM, Esperidiao MA, Andrade SKAV, Silva JFM, et al
Governance and responses of health and surveillance systems to COVID-19 in BRICS countries: A scoping review protocol.
PLoS One. 2025;20:e0319572.
PubMed Abstract available - GU Z, Luo X, Sun R, Xi T, et al
Long-term effects of the COVID-19 lockdown on the structural and functional outcomes of neovascular AMD patients in Suzhou, China.
PLoS One. 2025;20:e0319677.
PubMed Abstract available - AGHA S, Nazir S, Kaleem M, Najeeb F, et al
Performance evaluation of reduced complexity deep neural networks.
PLoS One. 2025;20:e0319859.
PubMed Abstract available - HARUN SNF, Jasman N, Mustapha F, Jaafar N, et al
Noteworthy trends in maladaptive coping strategies and hindrances to help-seeking behaviour among adolescents living in Malaysia's People's Housing Project (PPR) during the COVID-19 pandemic: A qualitative study.
PLoS One. 2025;20:e0318381.
PubMed Abstract available - GRANADOS SAMAYOA JA, Moore CA, Ruisch BC, Ladanyi JT, et al
Is there anything good about conspiracy beliefs? Belief in COVID-19 conspiracy theories is associated with benefits to well-being.
PLoS One. 2025;20:e0319896.
PubMed Abstract available - OUAKOUAK ML, Ouedraogo N, Hewapathirana GI, Zaitouni M, et al
Role of leaders' positive mindset in mitigating the effects of crises on organizations: The case of Canadian organizations.
PLoS One. 2025;20:e0319931.
PubMed Abstract available - DOS S P ANDRADE AC, Lacasse E, Dubuc I, Gudimard L, et al
Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2025;122:e2420441122.
PubMed Abstract available - EILERSEN A, Bjornstad ON, Li R, Schreiber SJ, et al
Epidemic evolutionarily stable strategies within an age-structured host population.
Proc Natl Acad Sci U S A. 2025;122:e2418170122.
PubMed Abstract available - GAILLETON R, Mathew NR, Reusch L, Schon K, et al
Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination.
Proc Natl Acad Sci U S A. 2025;122:e2421724122.
PubMed Abstract available - PATTHAMMAVONG C, Wodniak N, Phounphenghack K, Tengbriacheu C, et al
Factors associated with influenza and COVID-19 vaccination among health workers in Lao PDR, 2023.
Vaccine. 2025;54:127006.
PubMed Abstract available - HEGMANN TE, Walter EB, Smith MJ, Campbell J, et al
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone(R) or Flublok(R)) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age.
Vaccine. 2025;54:126991.
PubMed Abstract available - THORS V, Vias RD, Bjornsdottir K, Palsdottir EB, et al
Influenza vaccine effectiveness in Iceland 2014-2022: A test-negative design.
Vaccine. 2025;55:126981.
PubMed Abstract available - CAVARELLI M
Ghosts of the virus : unmasking the persistent threat of SARS-CoV-2 in Long COVID.
Virologie (Montrouge). 2025;29:57-68.
PubMed Abstract available - CAVARELLI M
[Ghosts of the virus : unmasking the persistent threat of SARS-CoV-2 in Long COVID].
Virologie (Montrouge). 2025;29:41-53.
PubMed Abstract available - BENLARBI M, Kenfack DD, Dionne K, Cote-Chenette M, et al
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
Virology. 2025;605:110467.
PubMed Abstract available
Am J Med
Comments
Post a Comment